German-based BioNtech and American company Pfizer on Friday claimed that their vaccine could be preserved at a much higher temperature than before. This will make it easier to make cold chains of these vaccines and move them from one place to another.
The company says it has sought permission from the US Fund and Drug Association to preserve the corona vaccine at temperatures of -25 to 15 degrees Celsius for two weeks. This temperature remains in the pharmaceutical freezer or common fridge.
According to the current guidelines, Bioantec and Pfizer’s vaccine is kept at a temperature of -80 to -60 degrees five days before use. It needs extremely cold containers to move from one place to another and resort to dry ice.
Pfizer CEO Albert Bourla said that if it is approved, the pharmacy and vaccination centers would be more comfortable managing vaccine supplies.